Article info

Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy

Authors

  1. Correspondence to Dr Paul T Elkington, NIHR Biomedical Research Centre, School of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Hampshire, SO17 1BJ, UK; p.elkington{at}soton.ac.uk
View Full Text

Citation

Morelli T, Fujita K, Redelman-Sidi G, et al
Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy

Publication history

  • Received March 12, 2021
  • Accepted August 12, 2021
  • First published October 4, 2021.
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.